Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Vito J. Palombella"'
Autor:
Yu Yang, Ricard Masia, Yue Ren, Benjamin H Lee, Jonathan A Hill, Vito J Palombella, Karin Golan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a3a6f23fedec436288bbf68f16c6d31d
Autor:
Yu Yang, Ricard Masia, Yue Ren, Jonathan A Hill, Vito J Palombella, Robert R Haines, Marisella Panduro, James F Mohan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e97a4eea00494bcd80e074d7a4cbb66a
Autor:
Michael C. Warren, Stephan Matissek, Matthew Rausch, Marisella Panduro, R. J. Hall, Austin Dulak, David Brennan, Sonia Das Yekkirala, Secil Koseoglu, Ricard Masia, Yu Yang, Navamallika Reddy, Robert Prenovitz, Jamie Strand, Tauqueer Zaidi, Erik Devereaux, Célia Jacoberger Foissac, John Stagg, Benjamin H. Lee, Pamela Holland, Vito J. Palombella, Andrew C. Lake
Publikováno v:
ImmunoHorizons. 7:366-379
CD39 (ENTPD1) is a key enzyme responsible for degradation of extracellular ATP and is upregulated in the tumor microenvironment (TME). Extracellular ATP accumulates in the TME from tissue damage and immunogenic cell death, potentially initiating proi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::730fecc8a4a2e77108479d6425a15698
https://doi.org/10.4049/immunohorizons.2200089
https://doi.org/10.4049/immunohorizons.2200089
Autor:
Emmanuel Normant, Ammar Adam, Marisa O Peluso, Caroline M Armet, Rachel W O’Connor, Benjamin H Lee, Andrew C Lake, Scott C Chappel, Jonathan A Hill, Vito J Palombella, Pamela M Holland, Alison M Paterson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background CD47 is a broadly expressed cell surface glycoprotein associated with immune evasion. Interaction with the inhibitory receptor signal regulatory protein alpha (SIRPα), primarily expressed on myeloid cells, normally serves to restrict effe
Externí odkaz:
https://doaj.org/article/5c5412f6b8c54e9fb65a54d23faabf2e
Autor:
Emmanuel Normant, Ammar Adam, Marisa O Peluso, Caroline M Armet, Rachel W O’Connor, Benjamin H Lee, Andrew C Lake, Scott C Chappel, Jonathan A Hill, Vito J Palombella, Pamela M Holland, Alison M Paterson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/34e032f627ae4a6d846f6d6f415f432a
Autor:
Emmanuel Normant, Ammar Adam, Marisa O Peluso, Caroline M Armet, Rachel W O’Connor, Benjamin H Lee, Andrew C Lake, Scott C Chappel, Jonathan A Hill, Vito J Palombella, Pamela M Holland, Alison M Paterson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/93d6a928909b49afa8f4b2ad84fd8e0a
Autor:
Emmanuel Normant, Ammar Adam, Marisa O Peluso, Caroline M Armet, Rachel W O’Connor, Benjamin H Lee, Andrew C Lake, Scott C Chappel, Jonathan A Hill, Vito J Palombella, Pamela M Holland, Alison M Paterson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/a4d9cd0360854418a745d8ab1452150e
Autor:
Marisella Panduro, Yue Ren, Ricard Masia, Yu Yang, Andrew C. Lake, Vito J. Palombella, Jonathan A. Hill, James F. Mohan
Publikováno v:
Cancer Research. 83:5125-5125
FOXP3+ regulatory T (Treg) cells play a crucial role in orchestrating immune responses across several tissues, including the tumor microenvironment (TME). The dominant immune regulatory activity of Treg cells is evidenced, both clinically and preclin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2830d10e0d4ff045fe2ab895f56e6f08
https://doi.org/10.1158/1538-7445.am2023-5125
https://doi.org/10.1158/1538-7445.am2023-5125
Autor:
Jing Hua, Turan Aghayev, Secil Koseoglu, Matthew Rausch, Sergei I. Grivennikov, Benjamin H. Lee, Jonathan A. Hill, Aleksandra M. Mazitova, Ekaterina K. Koltsova, Ricard Masia, Kerry White, Kerry S. Campbell, Pamela M. Holland, Devapregasan Moodley, Vito J. Palombella
Publikováno v:
Immunology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6f440ab86a85058d3a5366a9b5b07b9
https://doi.org/10.1158/1538-7445.am2021-1607
https://doi.org/10.1158/1538-7445.am2021-1607
Autor:
Brenda C O'Connell, Katie O'Callaghan, Bonnie Tillotson, Mark Douglas, Nafeeza Hafeez, Kip A West, Howard Stern, Janid A Ali, Paul Changelian, Christian C Fritz, Vito J Palombella, Karen McGovern, Jeffery L Kutok
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115228 (2014)
HSP90 inhibitors are currently undergoing clinical evaluation in combination with antimitotic drugs in non-small cell lung cancer (NSCLC), but little is known about the cellular effects of this novel drug combination. Therefore, we investigated the m
Externí odkaz:
https://doaj.org/article/9d093119cf444dc3945b927b8fef1652